Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence

Psychopathology

Volumn 42, Issue 5, 2009, Pages 311-317

  Barbui, Corrado ^a   Kikkert, Martijn ^b   Mazzi, Maria Angela ^a   Becker, Thomas ^c,d   Bindman, Jonathan ^e   Schene, Aart ^b   Nosè, Michela ^a   Helm, Hedda ^c   Thornicroft, Graham ^e   Tansella, Michele ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Clinician perspective; Patient perspective; Treatment adherence

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SCORING SYSTEM; SOCIAL ASPECT; TREATMENT DURATION; UNEMPLOYMENT; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; EUROPE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIOECONOMIC FACTORS;

EID: 68349109550     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232973     Document Type: Article

References (27)

1. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005;353:487-497.
2. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909.
3. Nose M, Barbui C, Tansella M: How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med 2003;33:1149-1160. (Pubitemid 37265204)
4. Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001;52:805-811.
5. Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, et al: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002;40:630-639.
6. Ascher-Svanum H, Faries D, Zhu B, Ernst F, Swartz M, Swanson J: Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 2006;67:453-460.
7. Thieda P, Beard S, Richter A, Kane J: An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr Serv 2003;54:508-516. (Pubitemid 36752981)
8. Nichol MB, Venturini F, Sung JC: A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999;33:531-540. (Pubitemid 29255059)
9. Kane JM: Problems of compliance in the outpatient treatment of schizophrenia. J Clin Psychiatry 1983;44:3-6.
10. Hogan TP, Awad AG, Eastwood R: A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:177-183.
11. Thompson K, Kulkarni J, Sergejew AA: Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241-247. (Pubitemid 30216535)
12. Barbui C, Nose M, Bindman J, Schene A, Becker T, Mazzi MA, et al: Sex differences in the subjective tolerability of antipsychotic drugs. J Clin Psychopharmacol 2005;25:521-526. (Pubitemid 41669042)
13. Gray R, Leese M, Bindman J, Becker T, Burti L, David A, et al: Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatry 2006;189:508-514. (Pubitemid 44876869)
14. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al: SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990;47:589-593.
15. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
16. Kemp R, Kirov G, Everitt B, Hayward P, David A: Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry 1998;172:413-419. (Pubitemid 28204550)
17. Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, Van WB: Client Socio-Demographic and Service Receipt Inventory - European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: inputs linked to outcome domains and needs. Br J Psychiatry Suppl 2000;39:S28-S33.
18. Ruggeri M, Koeter M, Schene A, Bonetto C, Vazquez-Barquero JL, Becker T, et al: Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries. Schizophr Res 2005;75:107-117. (Pubitemid 40487979)
19. Jones SH, Thornicroft G, Coffey M, Dunn G: A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry 1995;166:654-659.
20. Day JC, Wood G, Dewey M, Bentall RP: A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry 1995;166:650-653.
21. Zellner A: An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias. J Am Stat Assoc 1962;57:348-368.
22. Fonda SJ, Herzog AR: Patterns and risk factors of change in somatic and mood symptoms among older adults. Ann Epidemiol 2001;11:361-368.
23. Becker T, Hulsmann S, Knudsen HC, Martiny K, Amaddeo F, Herran A, et al: Provision of services for people with schizophrenia in five European regions. Soc Psychiatry Psychiatr Epidemiol 2002;37:465-474. (Pubitemid 36067970)
24. David AS: Insight and psychosis. Br J Psychiatry 1990;156:798-808.
25. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV: Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res 2003;63:49-58. (Pubitemid 36929845)
26. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, et al: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004;161:692-699. (Pubitemid 38445514)
27. Dolder CR, Lacro JP, Dunn LB, Jeste DV: Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 2002;159:103-108.